Management of Mild Cognitive Impairment

Mild cognitive impairment (MCI) is a prodromal syndrome often linked to the eventual emergence of dementia syndromes such as Alzheimer’s disease (AD) and vascular dementia (VaD). Research regarding the potential treatment of MCI is reviewed. Current research suggests that neurocognitive decline associated with MCI that may evolve into a dementia syndrome is potentially managed by treating cardiovascular risk factors, appropriate diet and physical exercise, challenging mental activity, intervention for any neuropsychiatric issues, and encouraging meaningful psychosocial relationships. Recent research also suggests potentially better effect on neuropsychological functioning when medication such as donepezil is used to manage both dementia and MCI.